Skip to content
← Full study record

NCT01190644 · OUTCOME

Change From Baseline in Erythropoietin Levels

Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors · Source last updated 2023-11-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
IU/L
Interval / dispersion
Full Range
Time frame
Baseline (Day 1, pre-dose) and Day 211

What was measured

Blood samples were collected at baseline (Day 1, pre-dose) and at Day 211 to measure the change from baseline in erythropoietin levels.

Analysis population: All participants who received at least one dose of study treatment and had data for Change from Baseline in Erythropoietin Levels

Groups in this outcome

Sotatercept

Participants received a single 35 mg dose of sotatercept by SC injection on Day 1, Day 43, and Day 85.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Sotatercept1

Reported measurements

Source class 1
Values in IU/L · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Sotatercept11.30Not reported11.311.3Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        11.3
        upper Limit
        11.3
        value
        11.30
denoms
  1. counts
    1. group Id
      OG000
      value
      1
    units
    Participants
description
Blood samples were collected at baseline (Day 1, pre-dose) and at Day 211 to measure the change from baseline in erythropoietin levels.
dispersion Type
Full Range
groups
  1. description
    Participants received a single 35 mg dose of sotatercept by SC injection on Day 1, Day 43, and Day 85.
    id
    OG000
    title
    Sotatercept
param Type
MEAN
population Description
All participants who received at least one dose of study treatment and had data for Change from Baseline in Erythropoietin Levels
reporting Status
POSTED
time Frame
Baseline (Day 1, pre-dose) and Day 211
title
Change From Baseline in Erythropoietin Levels
type
SECONDARY
unit Of Measure
IU/L

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice